Therefore, the experiment was not performed here; (4) SREBP1c-PNPLA3 pathway has been regarded as a “disease module” that promotes hepatic fibrogenesis [94] while the latter is associated with the progression of NASH. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatohepatitis.